Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

5 Reasons To Add Broadridge Financial (BR) To Your Portfolio

Published 05/28/2019, 05:15 AM
Updated 07/09/2023, 06:31 AM
NCI_old
-
WEX
-
BR
-
CPAY
-

A wise investment decision involves buying well-performing stocks at the right time while selling those that are at risk. A rise in share price and strong fundamentals signal a stock’s bullish run.

Here we focus on Broadridge Financial Solutions, Inc. (NYSE:BR) , an outsourcing stock that has performed extremely well so far this year and has the potential to carry the momentum forward. Therefore, if you haven’t taken advantage of the share price appreciation yet, it’s time you add the stock to your portfolio.

Why an Attractive Pick?

Share Price Appreciation: A glimpse of the company’s price trend reveals that the stock has had an impressive run on the bourse over the past year. Broadridge returned a 28.8%, which compared favorably with the industry’s 25.7% growth.

Solid Rank & VGM Score: Broadridge has a Zacks Rank #2 (Buy) and a VGM Score of B. Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment. You can see the complete list of today’s Zacks #1 Rank stocks here.

Northward Estimate Revisions: Two estimates for fiscal 2019 moved north over the past 30 days versus one southward revision, reflecting analysts’ confidence in the company. Over the same period, the Zacks Consensus Estimate for fiscal 2019 climbed 0.6%.

Solid Growth Prospects: The Zacks Consensus Estimate for fiscal 2019 earnings of $4.65 reflects year-over-year growth of 11%. Earnings are expected to grow 9.5% in fiscal 2020. The expected long-term earnings per share growth rate for Broadridge stands at 10%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Growth Factors

Broadridge is progressing well with its key growth initiatives. It is strengthening its governance business through developing next-generation regulatory communications. It is providing integrated technology platforms to capital markets and wealth management clients for reduction of cost and complexity of operations.

The company is making significant investments in digital, AI, cloud and blockchain that are expected to enhance the value of its core product offerings over time. Consistent demand for technology solutions globally should help Broadridge gain significantly from its SaaS based offerings. Growing trends like growing demand for data and analytics, mutualization and digitization should drive sales.

The recent acquisition of TD Ameritrade's retirement custody and trust assets is expected to strengthen the company’s position as a leading third-party provider of fund trading, deprocessing and custodial solutions. Another recent acquisition, that of Rockall Technologies, expands the company’s wealth management product line and provides new front office capabilities.

Other Stocks to Consider

Some other top-ranked stocks in the broader Zacks Business Services sector are Navigant Consulting (NYSE:NCI) , WEX (NYSE:WEX) and FLEETCOR Technologies (NYSE:FLT) . While Navigant Consulting sports a Zacks Rank #1, WEX and FLEETCOR carry a Zacks Rank #2.

Long-term expected EPS (three to five years) growth rate for Navigant Consulting, WEX and FLEETCOR is 13.5%, 15% and 16%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



FleetCor Technologies, Inc. (FLT): Free Stock Analysis Report

WEX Inc. (WEX): Free Stock Analysis Report

Navigant Consulting, Inc. (NCI): Free Stock Analysis Report

Broadridge Financial Solutions, Inc. (BR): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.